eResearchTechnology To Present At The AeA Classic Financial Conference In San Diego, California
PHILADELPHIA, Nov. 1 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. , a leading provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today that its Chief Financial Officer, Bruce Johnson, will present at the AeA Classic Financial Conference. The conference is hosted by the Manchester Grand Hyatt Hotel in San Diego, California from November 7-9. eRT is scheduled to present in Session I, which offers 8 presentations between 8 A.M. and 5:15 P.M. on Monday, November 7th and 3 presentations between 8 A.M. and 10:45 A.M. on Tuesday, November 8th. eRT's presentation will be held in room 639.
Interested parties can visit http://www.ert.com or http://www.aeanet.org/events to access a webcast of the presentation.
About the AeA Classic Financial Conference
In its 34th year, the AeA Classic Financial Conference continues to provide public technology companies with an environment in which to showcase their companies to key technology investors. In this exclusive three-day conference, company executives present their technologies, strategic missions, trend analysis and other significant information to a focused group of investors. Designed to use time efficiently, the conference is broken up into two sessions. Each company will be assigned their own private meeting room where they will each host multiple 45-minute meetings with investors.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.eResearchTechnology, Inc.
CONTACT: Bruce Johnson of eResearchTechnology, Inc., +1-215-282-5580; MattHayden of Hayden Communications, +1-858-704-5065